FOXL2 and non-small cell lung carcinoma: Generally, miR‐133b downregulates FOXL2 by targeting the 3′‐UTR of FOXL2, thereby inhibiting cell proliferation, EMT, and metastasis induced by the TGF‐β/Smad signaling pathway in NSCLC.